European fermentation firms unite

- Last updated on GMT

European fermentation firms unite

Related tags: Nutrition

French yeast and cultures specialist Lesaffre has taken a majority share in Italian fermentation biotech firm Gnosis.

The French firm said it sought to strengthen its presence and its offering in the fast-growing nutritional ingredients and human health sector.”

Lesaffre paid an undisclosed sum to the Maccaferri Group for the shares it acquired in Gnosis in 2002. Maccaferri said it was selling up because it was focusing its on renewable energy.

Gnosis has two production facilities in Italy and Switzerland and an estimated turnover of €80m this calendar year.

The synergies that we will develop between Lesaffre and Gnosis will enable us to improve our production processes and offer products and services that are increasingly innovative and closely matched to customer and consumer needs,"​ Lesaffre CEO Antoine Baule said in a statement.

Gnosis, founder Aldo Basseti said “This new partnership will enable Gnosis to consolidate its position, and to move into a new phase in its growth."

Gnosis employs about 200 people and its portfolio of fermented ingredients includes vitamins like folate, antioxidants, probiotics and enzymes.

Related news

Show more

Related products

show more

Is green the new colour for lutein?

Is green the new colour for lutein?

LEHVOSS Nutrition– Gee Lawson | 04-Nov-2019 | Application Note

Green solvents minimise the environmental impact resulting from the use of industrial solvents in the chemical raw material production. Green solvents...

Phytosome: the biomimetic delivery system

Phytosome: the biomimetic delivery system

Indena: the botanical ingredient of Health Food industry | 07-Oct-2019 | Application Note

Bioavailability is widely recognized as a central issue in the nutraceutical field. With almost a century of history on scientific know-how on its site,...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars